Patent · US Active

Drug delivery devices and methods

US9549846B2 · kind B2 · utility

5Cited by

184References

13Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Luke W. Clauson · Reno, US
Thomas A. Silvestrini · Alamo, US
Tsontcho Ianchulev · Harrison, US
Steven John · Menlo Park, US

Key dates

Filing date	Jul 27, 2015
Grant date	Jan 24, 2017
Priority date	—
Expiry date	Jul 27, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates generally to methods and devices for use in treating eye conditions with implantable drug delivery devices. One method includes introducing an implant into the suprachoroidal space, wherein the interior volume of the implant is plugged with a drug-release material comprising at least one active agent that elutes through at least one opening in the implant, wherein the drug-release material degrades from the interior volume of the implant over a period time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.